Literature DB >> 31590929

Antigen-specific immunotherapy for MOG antibody-associated diseases.

Stefan Nessler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31590929      PMCID： PMC6838443          DOI： 10.1016/j.ebiom.2019.09.029

Source DB:  PubMed          Journal:  EBioMedicine        ISSN： 2352-3964            Impact factor:   8.143


× No keyword cloud information.
  9 in total

1.  Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.

Authors:  Matthias Baumann; Eva-Maria Hennes; Kathrin Schanda; Michael Karenfort; Barbara Kornek; Rainer Seidl; Katharina Diepold; Heinz Lauffer; Iris Marquardt; Jurgis Strautmanis; Steffen Syrbe; Silvia Vieker; Romana Höftberger; Markus Reindl; Kevin Rostásy
Journal:  Mult Scler       Date:  2016-02-11       Impact factor: 6.312

2.  Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Authors:  Yael Hacohen; Yu Yi Wong; Christian Lechner; Maciej Jurynczyk; Sukhvir Wright; Bahadir Konuskan; Judith Kalser; Anne Lise Poulat; Helene Maurey; Esther Ganelin-Cohen; Evangeline Wassmer; Chery Hemingway; Rob Forsyth; Eva Maria Hennes; M Isabel Leite; Olga Ciccarelli; Banu Anlar; Rogier Hintzen; Romain Marignier; Jacqueline Palace; Matthias Baumann; Kevin Rostásy; Rinze Neuteboom; Kumaran Deiva; Ming Lim
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

3.  Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation.

Authors:  Chao Gu; Lei Wang; Sandra Zurawski; SangKon Oh
Journal:  J Immunol       Date:  2019-06-07       Impact factor: 5.422

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

5.  Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Authors:  Maciej Jurynczyk; Silvia Messina; Mark R Woodhall; Naheed Raza; Rosie Everett; Adriana Roca-Fernandez; George Tackley; Shahd Hamid; Angela Sheard; Gavin Reynolds; Saleel Chandratre; Cheryl Hemingway; Anu Jacob; Angela Vincent; M Isabel Leite; Patrick Waters; Jacqueline Palace
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

6.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

7.  Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.

Authors:  Dapeng Li; Gabrielle Romain; Anne-Laure Flamar; Dorothée Duluc; Melissa Dullaers; Xiao-Hua Li; Sandra Zurawski; Nathalie Bosquet; Anna Karolina Palucka; Roger Le Grand; Anne O'Garra; Gerard Zurawski; Jacques Banchereau; Sangkon Oh
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

8.  Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10).

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Michela Comi; Daniele Avancini; Francesca Santoni de Sio; Matteo Villa; Molly Javier Uyeda; Matteo Floris; Daniela Tomasoni; Alessandro Bulfone
Journal:  Cell Mol Immunol       Date:  2019-03-06       Impact factor: 11.530

9.  Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques.

Authors:  Claire-Maëlle Fovet; Lev Stimmer; Vanessa Contreras; Philippe Horellou; Audrey Hubert; Nabila Seddiki; Catherine Chapon; Sabine Tricot; Carole Leroy; Julien Flament; Julie Massonneau; Nicolas Tchitchek; Bert A 't Hart; Sandra Zurawski; Peter Klucar; Philippe Hantraye; Kumaran Deiva; Gerard Zurawski; SangKon Oh; Roger Le Grand; Ché Serguera
Journal:  EBioMedicine       Date:  2019-09-03       Impact factor: 8.143
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.